Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 112 Bortezomib 61 Lenalidomide 49 Cyclophosphamide 49 Calcium Dobesilate 43 pomalidomide 32 Melphalan 31 fludarabine 25 Filgrastim 25 carfilzomib 22 fludarabine phosphate 21 daratumumab 20 Granulocyte Colony-Stimulating Factor 16 Whole-Body Irradiation 15 Antilymphocyte Serum 15 dexamethasone acetate 14 Mycophenolic Acid 14 Thalidomide 13 Tacrolimus 13 Cyclosporine 13 Busulfan 13 Peripheral Blood Stem Cell Transplantation 12 ixazomib 11 dexamethasone 21-phosphate 10 auricularum 10 pembrolizumab 9 Radiotherapy 9 Etoposide 9 belantamab mafodotin 8 Rituximab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Multiple Myeloma × darlin protein, Dictyostelium × Clear all

NCT03481556 2022-12-19

ANCHOR

Oncopeptides AB

Phase 1/2 Terminated

56 enrolled 22 charts

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡